Charles River Laboratories | CRL - Des Atouts

Prix De L'Action
151.97
Variation Quotidienne
-3.49 -2.25%
Mensuellement
-4.14%
Annuel
-13.17%
Q1 Prévisions
150.77




Des Atouts Changement Date
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.23B 141K 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Cardinal Health USD 58.08B 2.86B 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cigna USD 157.92B 0 2025-12
Concord Medical Services Hldg CNY 6.07B 65.14M 2023-06
CVS Health USD 253.54B 1.79B 2025-12
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Elevance Health USD 121.49B 1.26B 2025-12
Galapagos EUR 3.41B 105.39M 2025-12
Hologic USD 9.18B 165.8M 2025-12
Humana USD 48.91B 810M 2025-12
Illumina USD 6.64B 467M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 84.19B 30M 2025-12
Merck EUR 51.53B 600M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Quest Diagnostics USD 16.23B 28M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12
UnitedHealth USD 309.58B 5.69B 2025-12
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 5.08B 221.41M 2025-12
West Pharmaceutical Services USD 4.27B 164.2M 2025-12